REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 133 filers reported holding REATA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,700,000 | -25.9% | 11,779 | +4.9% | 0.53% | +4.6% |
| Q4 2019 | $2,295,000 | +212.2% | 11,228 | +22.7% | 0.50% | +160.3% |
| Q3 2019 | $735,000 | -73.1% | 9,150 | -68.4% | 0.19% | -71.0% |
| Q2 2019 | $2,730,000 | -15.8% | 28,933 | -23.7% | 0.67% | -16.0% |
| Q1 2019 | $3,241,000 | +54.5% | 37,917 | +1.4% | 0.80% | +39.5% |
| Q4 2018 | $2,098,000 | -59.4% | 37,406 | -40.8% | 0.57% | -25.8% |
| Q3 2018 | $5,165,000 | – | 63,177 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |